Eurand is developing and commercializing our own portfolio of therapeutic products in the U.S. to address conditions associated with cystic fibrosis and gastrointestinal disorders.
Eurand (NASDAQ: EURX) is a global specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and biopharmaceutical products based on its proprietary drug formulation technologies.
Product Licensing Opportunities
Eurand has a portfolio of existing products available in a variety of therapeutic categories.
Eurand has a range of products in various stages of development.
Click NowPharmaceutical technologies for formulation development and life cycle management solutions.
Click NowLearn more about Eurand’s portfolio of products available for out-licensing
Click NowAMRIX® is a registered trademark of Cephalon, Inc., or its affiliates
Zenpep® is a registered trademark of Eurand Pharmaceuticals, Ltd.
